Four Years After Dobbs: The Impact on State Abortion Policies

The Dobbs decision, which overturned Roe v. Wade in 2022, returned abortion policy authority to U.S. states. Four years later, NPR reporter Selena Simmons-Duffin examines how this shift has reshaped access to reproductive healthcare across the country, revealing stark disparities and evolving legal landscapes.

Since the Supreme Court’s 2022 ruling in Dobbs v. Jackson Women’s Health Organization, 14 states have enacted strict abortion bans, while 36 states and Washington, D.C., have maintained or expanded protections. This division has created a patchwork of access, with patients in restrictive states often traveling across state lines or relying on telemedicine and mail-order pills to obtain care.

Telemedicine and Mifepristone Access Remain Contested

Recent developments underscore the ongoing legal battles over medication abortion. In late May 2026, the U.S. Supreme Court temporarily extended access to mifepristone, the primary drug used in non-surgical abortions, allowing its distribution via telemedicine and mail for at least three more days. This decision came after lower courts had blocked the drug’s availability under new FDA guidelines, highlighting the volatility of reproductive healthcare policy.

Simmons-Duffin’s reporting emphasizes that while some states have codified protections for abortion access, others have implemented stringent restrictions. For example, Texas and Oklahoma maintain near-total bans, while states like California and New York have passed laws shielding patients and providers from out-of-state enforcement efforts.

Impact on Marginalized Communities

Health advocates warn that restrictive policies disproportionately affect low-income individuals, rural populations, and people of color. A 2025 study published in the Journal of the American Medical Association found that patients in states with abortion bans faced significantly higher travel costs and delays in care, increasing the risk of complications. “The burden of navigating these barriers falls heaviest on those with the least resources,” said Dr. Rachel Jones, a reproductive health researcher at the Guttmacher Institute.

In some regions, underground networks and nonprofit organizations have stepped in to fill gaps. For instance, the nonprofit I-Need-Abortion, which operates in multiple states, reported a 40% increase in requests for financial assistance between 2023 and 2025. However, these efforts remain limited in scope and face legal challenges in restrictive states.

Legal and Political Uncertainty

The evolving legal landscape has left providers and patients in a state of flux. In June 2026, the Supreme Court agreed to hear a case challenging the FDA’s approval of mifepristone, which could further destabilize access. Meanwhile, state legislatures continue to introduce bills targeting abortion providers, with some proposals seeking to criminalize cross-border care.

Simmons-Duffin’s analysis highlights the broader implications of these developments. “The Dobbs decision wasn’t just about abortion—it set a precedent for how federalism shapes access to essential healthcare,” she noted. “What happens next will depend on how courts and lawmakers balance individual rights against state interests.”

As the 2026 midterm elections approach, abortion access remains a central issue for voters. Campaigns in key battleground states have focused on reproductive rights, with some candidates pledging to protect or expand access. However, the long-term stability of these policies remains uncertain, as legal challenges and political shifts continue to shape the future of healthcare in the U.S.